Abich Financial Wealth Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-143
Closed -$914 – 595
2024
Q2
$914 Buy
+143
New +$918 ﹤0.01% 627

Other funds holding HCAT

Abich Financial Wealth Management's HCAT Position: Q3 2024 in Review

Abich Financial Wealth Management sold out of Health Catalyst (HCAT) in Q3 2024, closing a stake of 143 shares — an estimated $914 sold.

Abich Financial Wealth Management first reported a position in HCAT in Q2 2024 and held it in 1 quarter. The position peaked at $914 in Q2 2024. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.

  • Abich Financial Wealth Management reported no remaining Health Catalyst position as of Q3 2024 after selling out during the quarter.
  • Abich Financial Wealth Management sold 143 Health Catalyst shares in Q3 2024, an estimated $914.
  • Abich Financial Wealth Management first reported a position in Health Catalyst in Q2 2024 and held it in 1 quarter.
  • Abich Financial Wealth Management's Health Catalyst position peaked at $914 in Q2 2024.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.

Based on Abich Financial Wealth Management's 13F filing for Q3 2024, filed 25 Oct 2024.